Salam Titinchi | Stem Cell Research | Editorial Board Member

Prof. Dr. Salam Titinchi | Stem Cell Research | Editorial Board Member

University of the Western Cape | South Africa

Professor J.J. Titinchi is an established chemist with extensive expertise in inorganic, organic, and materials chemistry, with a strong emphasis on functional materials and catalytic systems. His research focuses on the design, synthesis, and application of heterogeneous catalysts, nanostructured materials, metal–organic frameworks, and functional inorganic materials for sustainable chemical processes, including green chemistry, energy conversion, and environmental remediation. With over three decades of academic experience, he has made significant contributions to advancing structure–property relationships in catalytic and functional materials and their industrial and environmental applications. His scholarly output reflects consistent impact, with an h-index of 25 (Scopus) and approximately 1,760 citations, underscoring the relevance of his work in materials and chemical sciences. He has supervised a substantial number of postgraduate researchers, contributing to capacity building and knowledge transfer in advanced chemistry research. His international research engagement is reflected through collaborative programs and visiting professorships, particularly in the United States and Europe. In addition, he has played a leading role in shaping the scientific community through organizing and chairing international conferences on functional materials, chemical engineering, and nanotechnology. His sustained research productivity and recognition as an established researcher highlight his significant contribution to contemporary chemical and materials research.

Profile: Scopus

Featured Publications:

Titinchi, J. J., et al. (2025). C4C recent developments: Carbonaceous-supported catalysts for CO₂ conversion into cyclic carbonates. [Journal name not specified].

Titinchi, J. J., et al. (2024). Overcoming curcumin’s limitations: Synthetic derivatives in diabetes and cancer management. [Journal name not specified].

Titinchi, J. J., et al. (2025). Asymmetrical curcumin derivative: Synthesis, structural exploration, Hirshfeld surface analysis, and computational study. Structural Chemistry.

Titinchi, J. J., et al. (2025). Synthesis, in silico and antimicrobial activity study of substituted aromatic imines and their corresponding amines. Results in Chemistry.

Titinchi, J. J., et al. (2025). Fault seal analysis for geological carbon dioxide storage in the Pletmos Basin, offshore South Africa. Marine Georesources and Geotechnology.

Titinchi, J. J., et al. (2024). Evaluating the therapeutic potential of curcumin and synthetic derivatives: A computational approach to anti-obesity treatments. International Journal of Molecular Sciences.

Titinchi, J. J., et al. (2023). Medicinal chemistry perspectives on the development of piperazine-containing HIV-1 inhibitors. [Journal name not specified].

Titinchi, J. J., et al. (2023). Substituent and solvent effects on UV–visible absorption spectra of chalcone derivatives: Experimental and computational studies. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.

Titinchi, J. J., et al. (2023). Curcuminoid nanovesicles as advanced therapeutics. [Journal name not specified].

Tarun katheriya | Stem Cell Research | Research Excellence Award

Dr. Tarun katheriya | Stem Cell Research | Research Excellence Award

IIT BHU Varanasi | India

Tarun Katheriya is a physicist with extensive expertise in the synthesis, characterization, and analysis of advanced functional materials, particularly negative-permittivity ceramics, perovskites, and multifunctional composites for electromagnetic interference (EMI) shielding and wearable electronics. His Ph.D. research focused on developing epsilon-negative materials, including layered perovskites and glass-ceramics, with tunable dielectric and conductive properties. He has synthesized a variety of electro-ceramics and glass-ceramics, exploring their dielectric behavior through classical and modified Drude models, and demonstrated their EMI shielding effectiveness. Notably, his work includes investigating coil-less inductive properties in conducting ceramics and studying the electrochemical performance of these materials. Katheriya has contributed to understanding the correlation between conductivity and permittivity in doped perovskites, as well as high-temperature dielectric properties in layered oxides. His research integrates experimental synthesis with theoretical modeling, advanced characterization techniques such as XRD, SEM, impedance analysis, and vector network analysis, and simulation tools including FullProf, Zview, and Gaussian. His published work highlights innovations in metal-free nanocomposites, negative-permittivity behavior, and multifunctional EMI shielding, positioning him at the forefront of materials development for next-generation electronic applications.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications: 

  1. Katheriya, T., Pandey, S., & Upadhyay, S. (2025). New frontiers in ceramic composites: Tunable electromagnetic interference shielding by realizing negative permittivity in SnO₂/LaNiO₃ nanocomposites. Journal of Materials Chemistry C.

  2. Katheriya, T., Nirala, G., & Upadhyay, S. (2025). Study of negative permittivity in nanosized LaNiO₃ for electromagnetic interference shielding: A modified Drude model approach. ACS Applied Electronic Materials.

  3. Katheriya, T., Nirala, G., & Upadhyay, S. (2024). Establishing the correlation of negative permittivity and AC conductivity of La₂₋ₓSrₓNiO₄ (x = 0, 0.1, 0.3, 1.0) for microwave shielding applications. Journal of Materials Chemistry C, 12(23), 8473–8484.

  4. Katheriya, T., & Upadhyay, S. (2023). High-temperature study of dielectric and electrical conduction behavior of La₂NiO₄. Physica Scripta, 98(10), 105969.

  5. Verma, H., Mittal, A., Kumar, P., Katheriya, T., Bhattacharya, B., & Upadhyay, S. (2025). Enhanced supercapacitor performance of rGO-modified LaFeO₃ perovskite: Experimental and DFT insights. Materials Chemistry and Physics, 131771.

  1. Nirala, G., Katheriya, T., Yadav, D., Verma, H., & Upadhyay, S. (2023). The evolution of coil-less inductive behavior in La-doped Sr₂MnO₄. Emergent Materials, 6(6), 1951–1962. https://doi.org/[DOI if available]Nirala, G., Yadav, D., Katheriya, T., & Upadhyay, S. (2022). Temperature-dependent negative permittivity in solid solutions Sr₂Mn₁₋ₓSnₓO₄ (x = 0, 0.3, 0.5). Journal of the European Ceramic Society, 42(2), 453–461.

  2. Nirala, G., Katheriya, T., Yadav, D., Pandey, S., & Upadhyay, S. (2022). Effect of Nb doping on epsilon negative behaviour of Sr₂MnO₄. Journal of Materials Science, 57(33), 15862–15875.

  3. Mishra, R. K., Avinashi, S. K., Kumari, S., Nain, R., Katheriya, T., Dwivedi, R. K., … Gautam, C. (2024). Synergistic doping effect of La₂O₃ on BaO–TiO₂–SiO₂ glass-ceramics: Evolution of physical, structural, morphological, and dielectric behaviour for electronics applications. Journal of Alloys and Compounds, 990, 174354.

Tong Ming Liu | Stem Cell Research | Best Researcher Award

Dr. Tong Ming Liu |  Stem Cell Research | Best Researcher Award

Institute of Molecular and Cell Biology | Singapore

Dr. Tong Ming Liu’s research focuses on advancing gene and cell therapy through innovative studies on human mesenchymal stem cells (hMSCs) and induced pluripotent stem cells (iPSCs). His work explores the mechanisms governing mesenchymal stem cell stemness, potency, and ageing, with the goal of improving the therapeutic efficacy and manufacturing quality of MSC-based treatments. A central aspect of his research is identifying and characterizing critical quality attributes (CQAs) in MSC manufacturing to ensure consistent and safe clinical applications. Dr. Liu also investigates disease modeling of bone and cartilage disorders using iPSC-derived MSCs to facilitate drug screening and gene correction strategies. His recent projects include the development of optimized media for iPSC, iPSC-MSC, and MSC culture, as well as identifying novel biomarkers to select high-quality MSCs for regenerative medicine. Through his studies, he aims to enhance the scalability, functionality, and translational potential of stem cell therapies. His findings have been recognized in scientific forums such as the EVANTICA Symposium and Singapore Cell and Gene Therapy Conference, underscoring his contribution to the development of efficient MSC-derived extracellular vesicle (MSC-EV) optimization and regenerative therapy innovations.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Liu, T. M.*, Tew, W., Yang, Z., Lim, B., Hui, J. H. P., Lee, E. H., Loh, Y.-H., & Cool, S. (2025). Understanding the molecular basis of mesenchymal stem cell stemness: Implications for clinical applications. Cell Death & Disease, 16(1), 778.

Liu, T. M.* (2025). MSC-EVs: Pioneering the next generation of biomedical applications. World Journal of Stem Cells, 17(6), 108197.

Liu, T. M.*, & Wu, Y. (2023). Advancing gene and cell therapy using human mesenchymal stem cells. Frontiers in Cell and Developmental Biology, 11, 1294460.

Shou, Y., Liu, L., Le, Z., Lee, K. L., Li, X., Koh, D. Z., Wang, Y., Liu, T. M., Yang, Z., Lim, C. T., Cheung, C., & Tay, A. (2023). Mechano-responsive hydrogel for directing stem cell manufacturing and therapy. Bioactive Materials, 24, 387–400.

Liu, T. M.* (2021). Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine. World Journal of Stem Cells, 13(12), 1826–1844.

Srinivasan, A., Sathiyanathan, P., Yin, L., Liu, T. M., Lam, A., Ravikumar, M., Smith, R. A. A., Loh, H. P., Zhang, Y., Ling, L., Ng, S. K., Yang, Y. S., Lezhava, A., Hui, J., Oh, S., & Cool, S. M. (2022). Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion. Cytotherapy, 24(5), 456–472.

Liu, T. M.*, Yildirim, E. D., Li, P., Fang, H. T., Denslin, V., Kumar, V., Loh, Y.-H., Lee, E. H., Cool, S. M., Teh, B. T., Hui, J. H., Lim, B., & Shyh-Chang, N. (2020). Ascorbate and iron are required for the specification and long-term self-renewal of human skeletal mesenchymal stromal cells. Stem Cell Reports, 14(2), 210–225.

Arzu Yay | Stem Cell Research | Best Researcher Award

Prof. Dr. Arzu Yay | Stem Cell Research | Best Researcher Award

Erciyes University | Turkey

Prof. Arzu Yay is a distinguished researcher in the Department of Histology and Embryology at Erciyes University, Turkey. Her work focuses on cellular and molecular mechanisms underlying tissue development, injury, and repair, with emphasis on immunohistochemical and ultrastructural analyses. Her M.Sc. research examined E-cadherin expression during renal development in the prenatal period, contributing to the understanding of epithelial differentiation in organogenesis. Her Ph.D. focused on nestin expression across different grades of meningiomas and glioblastomas, highlighting neural stem cell marker dynamics in tumor progression. She has conducted significant studies on oxidative stress, neurobiology, and tissue damage, including investigations into the effects of melatonin and vitamin C on alcohol-induced lung injury and nitric oxide synthase immunoreactivity. Her research has also explored tissue-level alterations in diabetes and the histological impacts of hormonal and anesthetic agents. Prof. Yay’s postdoctoral work at the University of Lübeck, Germany, further advanced her expertise in dermatological histopathology. Her contributions have been recognized through multiple national and international awards for excellence in experimental and translational research, particularly in antioxidant mechanisms and radioprotection. Her body of work reflects a strong integration of histological, molecular, and ultrastructural approaches in biomedical sciences.

Profiles: Google Scholar | Scopus

Featured Publications:

Yıldız, K., Efesoy, S. N., Ozdamar, S., Yay, A., Bicer, C., Aksu, R., & Kılıc, E. (2011). Myotoxic effects of levobupivacaine, bupivacaine and ropivacaine in a rat model. Clinical Investigation in Medicine, 34(5), 273–280.

Sarıozkan, S., Bucak, M. N., Canturk, F., Ozdamar, S., Yay, A., Tuncer, P. B., Ozcan, S., Sorgucu, N., & Caner, Y. (2012). The effects of different sugars on motility, morphology and DNA damage during the liquid storage of rat epididymal sperm at 4°C. Cryobiology, 65(2), 93–97.

Sarıozkan, S., Canturk, F., Yay, A., & Akçay, A. (2012). The effect of different storage temperature on sperm parameters and DNA damage in liquid stored New Zealand rabbit spermatozoa. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, 18(3), 475–480.*

Yay, A., Ozdamar, S., Canoz, O., Tucer, B., & Baran, M. (2013). Nestin expression in meningiomas of different grades. Journal of Neurological Sciences (Turkish), 30, 532–540.

Sarıozkan, S., Türk, G., Canturk, F., Yay, A., Eken, A., & Akçay, A. (2013). The effect of bovine serum albumin and fetal calf serum on sperm quality, DNA fragmentation and lipid peroxidation of liquid stored rabbit semen. Cryobiology, 67(1), 1–6.*

Ernst, N., Yay, A., Bíró, T., Tiede, S., Humphries, M., Paus, R., & Kloepper, J. E. (2013). β1 integrin signaling maintains human epithelial progenitor cell survival in situ and controls proliferation, apoptosis and migration of their progeny. PLoS ONE, 8(12), e84356.*

Yay, A., Ozdamar, S., Canoz, O., Baran, M., Tucer, B., & Sonmez, M. F. (2014). Intermediate filament protein nestin is expressed in developing meninges. Bratislava Medical Journal, 115(11), 718–722.*

Hossein Abdizadeh | Tissue Engineering Regeneration | Best Researcher Award

Prof. Dr. Hossein Abdizadeh | Tissue Engineering Regeneration | Best Researcher Award

University of Tehran | Iran

Hossein Abdizadeh is a leading researcher in the field of materials engineering, specializing in the synthesis of nano-materials, semiconductors, and nano-structured composites. His research emphasizes the fabrication, characterization, and functional optimization of advanced ceramic and composite materials. His doctoral work focused on the development and analysis of duplex alumina-based three-layer laminated composites, exploring their structural and mechanical properties. He also investigated surface hydroxyl groups in ceramic materials using infrared spectrometry during his postgraduate studies, contributing to a deeper understanding of surface chemistry in ceramics. Over his career, he has led multiple university and industry-collaborative research projects, advancing applications of nano-structured materials in engineering contexts. Abdizadeh has a prolific publication record, with over 156 papers in international journals, numerous national and international conference contributions, and a Farsi-language book on chemical methods for producing nanoparticles. In 2009, he established the Nano-structured Materials and Composites Laboratory at the University of Tehran, fostering experimental research in advanced composites, nanomaterials, and their applications in metallurgy and materials science. His work combines experimental synthesis, microstructural characterization, and the study of material properties to develop innovative solutions in materials engineering and nanotechnology.

Profiles: Google Scholar | Scopus

Featured Publications:

Abdizadeh, H., Ghelich, R., Farhangian, M., Akbari Asbagh, R., Ahmadi Tafti, S. M., Foroutani, L., Chehresonboll, Y., & Poopak, A. (2025). Bioactive chitosan/polycaprolactone cryogel sponge co-loaded with ciprofloxacin and ginger for controlled drug release and healing of infected wounds. Materials & Design.

Abdizadeh, H., Khodabandeh, F., & Golobostanfard, M. R. (2025). Decoration of ZnO nanorod arrays with heterojunction of graphene quantum dots and MoS2 nanoparticles for photoelectrochemical water splitting. Applied Energy Materials.

Abdizadeh, H., Bakhshaei, P., & Ataie, A. (2024). Facile mechanical fabrication of Cu-Ni/CNT nanocomposite for improved microstructural, hardness, and electrical characteristics. Institute of Materials, Minerals & Mining.

Abdizadeh, H., Khodabandeh, F., Abdollahi Avanaki, A., & Golobostanfard, M. R. (2024). Photoelectrochemical water splitting based on chalcopyrite semiconductors: A review. International Journal of Hydrogen Energy, 65, 779–803.

Abdizadeh, H., Ghorbani, M., Sheibani, S., & Golobostanfard, M. R. (2024). Efficient synthesis of recyclable porous BiFeO3/rGO thin film via sol-gel method as an enhanced photocatalyst. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 686, 133429.

Abdizadeh, H., Beighi, M., Pourabdoli, M., & Raygan, Sh. (2023). Direct synthesis of tungsten carbide by solid‑state carbothermic reduction of tungsten trioxide. Transactions of the Indian Institute of Metals, 76(12), 3455–3461.

Inoussa Ilboudo | Stem Cell Research | Best Researcher Award

Mr. Inoussa Ilboudo | Stem Cell Research | Best Researcher Award

Nazi Boni University | Burkina Faso

Dr. Inoussa Ilboudo is an expert in food safety and post-harvest management of plant production, currently pursuing a doctoral thesis at Nazi Boni University (UNB) with a focus on food safety. He holds a master’s degree in post-harvest management of plant production from Joseph Ki-Zerbo University (UJKZ) and a license in applied human nutrition from IST. His professional experience spans food quality control, contaminant analysis, and agricultural product safety. Dr. Ilboudo has received specialized training in food contaminant analysis with Laval University (Canada), mycotoxin quantification using LC-MS/MS in Morocco, heavy metal analysis by atomic absorption spectrometry, GC-MS application in Pretoria, and chromatographic methods at the University of Helsinki. As Head of the Contaminants and Food Additives Department, he has led initiatives such as the implementation of peanut standards for infant flours and contributed to national food safety projects like ReCMA-BF. A member of the American Chemical Society, Dr. Ilboudo is also a certified master trainer under the GIZ/MOVE program and teaches quality control of fruits and vegetables in academic institutions. His research interests center on the assessment of food contaminants, post-harvest loss reduction, and the development of safer food systems in West Africa.

Profile: Orcid

Featured Publications:

Ilboudo, I., Compaoré, H., Compaoré, I., Traoré, S. M., Dembélé, L. E., Nikièma, F., Lanterbecq, D., Sawadogo‐Lingani, H., & Kabré, E. (2025). Biocontrol of aflatoxigenic maize molds using Lactobacillus spp.-based formulations. Food Science & Nutrition. Advance online publication.

 

Kelly Bosak | Stem Cell Research | Best Researcher Award

Dr. Kelly Bosak | Stem Cell Research | Best Researcher Award

University of Kansas Medical Center | United States

Dr. Kelly A. Bosak, PhD, APRN, ANP-BC, FHFSA, is a tenured Associate Professor at the University of Kansas Medical Center and a nationally recognized expert in heart failure care, nursing science, and implementation research. With a strong background in advanced practice nursing and nursing administration, Dr. Bosak has made significant contributions to interdisciplinary research focused on improving clinical outcomes in cardiology, rural health, and chronic disease management. Her peer-reviewed work spans high-impact journals such as The Journal of Cardiac Failure, Implementation Science, and The Journal for Nurse Practitioners, reflecting her leadership in both clinical practice and academic scholarship. Dr. Bosak has authored or co-authored over 30 peer-reviewed publications, with a Scopus h-index of 10, over 450 citations, and 32 documents indexed in major databases. She has played a pivotal role in national reports from the Heart Failure Society of America and led multiple implementation science projects aimed at integrating evidence-based interventions into routine care. Her current research emphasizes digital health innovation and workforce development in underserved communities. Dr. Bosak’s interdisciplinary collaborations and translational research continue to shape evidence-based practice and policy in cardiovascular nursing and advanced practice nursing education.

Profiles: Google Scholar | Scopus

Featured Publications:

  • “Return on Investment of a Nurse Practitioner Fellowship Program”

  • “Interprofessional Education for Improving Workforce Capacity to Treat COPD and Long COVID in Rural Communities”

  • “Shared Decision Making for the Pulmonary Artery Monitoring Device for Patients with Heart Failure”

  • “Implementation of a SmartPhrase for Exercise in the Electronic Health Record for Individuals with Heart Failure”

  • “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients: A Quality Improvement Project”

  • “Team Science”

  • “Ceramides as Novel Biomarkers of Cardiometabolic Conditions”

  • “Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America”

  • “Heart Failure Epidemiology and Outcomes Statistics, A Report of the Heart Failure Society of America”

  • “Implementation Mapping and Concept Mapping to Explore Guideline Implementation in the Heart Failure Clinic”

  • “Coordinating Resources for a Hybrid Effectiveness and Implementation Trial Across an Integrated Digital Network for Heart Failure”

  • “Creating a Standardized Approach to Program Evaluation in a Magnet Recognized Pediatric Hospital System”

 

 

 

Ali Alahmari | Stem Cell Transplantation | Best Researcher Award

Dr. Ali Alahmari | Stem Cell Transplantation | Best Researcher Award

Kfshrc | Saudi Arabia

Dr. Ali Alahmari is a distinguished consultant in Acute Leukemia, Hematology, Hematopoietic Stem Cell Transplantation (HSCT), and Cellular Therapy at King Faisal Specialist Hospital & Research Centre. He earned his MBBS degree from King Saud University and completed his internship at King Khalid University Hospital. He has held a key consultant position, contributing extensively to the advancement of cellular therapy and bone marrow transplantation in Saudi Arabia. Dr. Alahmari has made significant academic contributions to the field, particularly in hemato-hepatology and sickle cell disease. His research has focused on novel transplant approaches, including haploidentical stem cell transplantation after liver transplantation and donor impact in severe aplastic anemia. He has co-authored over 22 scientific documents, with his work accumulating more than 629 citations and earning an h-index of 12, reflecting the depth and influence of his research. His notable publications include titles such as Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia and Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction.” Dr. Alahmari’s ongoing efforts continue to shape clinical best practices and research frameworks for hematologic disorders and transplantation medicine in the region.

Profile: Scopus

Featured Publications:

  • “Author Correction: Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series”

  • “Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT”

  • “Emerging need for a hepato-hematology program for patients with sickle cell disease in Saudi Arabia”

  • “Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series”

  • “Hematopoietic Stem Cell Transplantation in Sickle Cell Disease”

  • “Setting up a Chimeric Antigen Receptor T Cell Therapy Program: A Framework for Delivery from the Worldwide Network for Blood & Marrow Transplantation”

  • “Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience”

Sedigheh Gharbi | Stem Cell Research | Best Researcher Award

Dr. Sedigheh Gharbi | Stem Cell Research | Best Researcher Award

Dr. Sedigheh Gharbi | Shahid Bahonar University of Kerman, Kerman, Iran | Iran

Assistant Prof. Dr. Sedigheh Gharbi is a dedicated Iranian biologist. She is currently an Assistant Professor at Shahid Bahonar University of Kerman, specializing in molecular biology with a strong focus on non-coding RNAs and their roles in cancer and cardiac regeneration. With over a decade of academic and research experience, Dr. Gharbi has contributed extensively to understanding microRNAs and long non-coding RNAs in disease mechanisms. She is recognized for her work on cardiomyocyte regeneration, cancer biology, and novel RNA regulatory networks. Dr. Gharbi has published numerous peer-reviewed articles, demonstrating her commitment to advancing biomedical research. Her research aims to translate molecular findings into potential therapeutic strategies, especially in oncology and regenerative medicine. She is also known for mentoring students and collaborating internationally to foster innovation in life sciences.

Publication Profile: 

Google Scholar

Education:

Dr. Sedigheh Gharbi completed her PhD in Molecular Biology at Tarbiat Modares University, Tehran. Her doctoral thesis focused on the microRNA expression profile alterations in serum and urine of sulfur mustard victims, under the supervision of Prof. Seyyed Javad Mowla. This work laid the foundation for her expertise in microRNAs and their diagnostic potential in toxicology and disease. Before her PhD, she earned a Master of Science degree from the University of Isfahan, where she conducted research on the mutational screening of the PIK3CA gene in breast cancer patients under Prof. Manoochehr Tavassoli. This early work sparked her interest in cancer genetics and molecular markers. Her education combined advanced molecular techniques with applied biomedical research, equipping her with the skills necessary for innovative studies in RNA biology and its implications in human diseases.

Experienc:

Since 2014, Dr. Gharbi has served as an Assistant Professor at Shahid Bahonar University of Kerman, where she lectures and leads research in molecular biology and cancer genetics. Her academic career is marked by active involvement in teaching, supervising graduate students, and securing research projects. She has a proven record in managing interdisciplinary studies focused on cardiomyocyte regeneration and RNA biology. Dr. Gharbi’s research experience spans molecular profiling of cancer biomarkers, non-coding RNA regulatory networks, and nanotechnology applications in drug delivery. She has collaborated with multiple research teams nationally and internationally, contributing to both fundamental science and translational medicine. Her role involves experimental design, bioinformatics analysis, and dissemination of findings through scientific publications and conferences. Dr. Gharbi’s experience in mentoring young scientists and publishing extensively positions her as a leader in her field.

Research Focus:

Dr. Gharbi’s primary research focus lies in the regulatory roles of non-coding RNAs—especially microRNAs (miRNAs) and long non-coding RNAs (lncRNAs)—in disease pathogenesis and therapy. She investigates cardiomyocyte regeneration by exploring how lncRNAs influence cell cycle progression, aiming to improve heart repair after injury. In oncology, her research centers on the regulatory structure of E-cadherin and the involvement of non-coding RNAs in cancer progression and management. Additionally, Dr. Gharbi is dedicated to identifying novel miRNAs and elucidating their functions in cellular processes like apoptosis and proliferation. Her work integrates molecular biology techniques with bioinformatics to uncover RNA-based biomarkers and therapeutic targets. The intersection of nanotechnology and RNA therapeutics is another emerging area in her studies, aiming to optimize cancer treatment delivery systems. Overall, her research contributes to understanding complex gene regulation mechanisms and developing RNA-based precision medicine strategies.

Publications Top Notes: 

  1. Mir-542 As A Potential and Promising Therapeutic Target For HPV-Positive Cervical Cancers

  2. CircPAN3/miR-221/PTEN Axis and Apoptosis in Myocardial Infarction: Quercetin’s Regulatory Effects

  3. Controlled cytotoxicity of Ag-GO nanocomposite biosynthesized using black peel pomegranate extract against MCF-7 cell line

  4. Characterization of the first microRNA in human CDH1 that affects cell cycle and apoptosis and indicates breast cancers progression

  5. Curcumin loaded on graphene nanosheets induced cell death in mammospheres from MCF-7 and primary breast tumor cells

  6. Bioinformatics Prediction of microRNAs Regulating Epithelial-to-Mesenchymal Transition in Cancer Cells

  7. Secondary toxic effect of graphene oxide and graphene quantum dots alters the expression of miR-21 and miR-29a in human cell lines

  8. Statins: Complex outcomes but increasingly helpful treatment options for patients

  9. Synthesis and characterization of d10 transition metal complexes in bulk and nano scales: DNA binding, molecular docking and anticancer activity against MCF-7 cell line

  10.  Quantification of circulating miR-517c-3p and miR-210-3p levels in preeclampsia

Conclusion:

In conclusion, Assistant Prof. Dr. Sedigheh Gharbi is highly suitable for the Best Researcher Award based on her consistent track record of innovative, impactful research and academic contributions. Her focus on molecular biology, especially the regulatory roles of non-coding RNAs in cancer and cardiac regeneration, addresses some of the most challenging issues in contemporary biomedical science. Her extensive publication record in reputable journals reflects the quality and significance of her work. While there are opportunities for further enhancing her international collaborations, funding portfolio, and translational efforts, her current achievements already mark her as a leading researcher with great potential for continued contributions. Awarding her the Best Researcher Award would recognize her scientific excellence and encourage further advancements in her promising research career.

 

Francesco Gaudio | Stem Cell Research | Best Researcher Award

Prof. Francesco Gaudio | Stem Cell Research | Best Researcher Award

Prof. Francesco Gaudio, LUM UNIVERSITY, Italy

Prof. Francesco Gaudio is a highly accomplished hematologist with over 20 years of clinical and academic expertise, specializing in lymphoproliferative neoplasms and hematopoietic stem cell transplantation. Currently serving as Assistant Professor in Hematology at University LUM Giuseppe Degennaro and a practicing medical doctor at “F. Miulli” Hospital, he has previously held long-term roles at renowned Italian hospitals. With a prolific research record, he has authored over 50 publications in high-impact journals and contributed more than 100 abstracts to international conferences. He has conducted research in leading global institutions, including Memorial Sloan-Kettering and Imperial College. Alongside clinical innovation, he is a passionate educator and experienced healthcare manager. His focus on therapeutic advances and multidisciplinary care makes him a leader in hematology research and oncology care.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Clinical and Academic Experience
    Over 20 years of dedicated work in hematology, with expertise in lymphoproliferative disorders and hematopoietic stem cell transplantation.

  2. Robust Research Profile

    • More than 50 peer-reviewed publications in Impact Factor journals.

    • 100+ abstracts presented internationally.

    • Principal and co-investigator in multinational clinical studies.

  3. Global Exposure & Collaborations
    Research training and collaborations at globally recognized centers:

    • Memorial Sloan-Kettering (USA)

    • Imperial College (UK)

    • Lyon Sud (France)

    • VHIO Barcelona (Spain)

  4. Commitment to Academic Growth

    • Teaches Blood Diseases, Oncology, and Pathology.

    • Holds National Scientific Qualification for Associate Professor level.

  5. Leadership & Management Training

    • Managerial courses from SDA Bocconi, ISTUD Foundation, and CURSUS.

  6. Multidisciplinary Impact
    Engages in translational research that bridges hematology, oncology, and emerging areas like cannabinoid therapies and survivorship in cancer.

⚠️ Areas for Improvement:

  1. Leadership in High-Impact Authorship
    While his contribution as co-author is commendable, increasing first or senior authorship in landmark studies would strengthen his research leadership visibility.

  2. Grant Leadership and Funding Acknowledgment
    No mention of competitive grant acquisition or principal leadership in major funded research networks; pursuing this could enhance academic competitiveness.

  3. Public Engagement and Open Science
    Could further boost impact by increasing participation in open-access platforms, public talks, and wider media dissemination of research findings.

🎓 Education:

Prof. Gaudio holds a Degree in Medicine and Surgery from the University of Bari (1995–1996), where he explored clonogenic hematopoietic activity in lymphoma patients. He specialized in Hematology (2001–2002), focusing on stem cell mobilization challenges. He further expanded his scientific foundation with a Postgraduate Specialization in Chemico-Pharmaceutical Research from CARSO (1998). Recognized for academic excellence, he earned the National Scientific Qualification (ASN) for Associate Professor in Hematology, Oncology, and Rheumatology in 2020. His academic path is complemented by top-tier executive and managerial training, including healthcare leadership programs from SDA Bocconi, ISTUD Foundation, and CURSUS. Early education includes a Classical High School Diploma from Liceo Classico ‘Quinto Ennio’, Taranto. His diverse education underscores a balanced mastery of clinical medicine, research, and institutional leadership.

💼 Professional Experience:

Prof. Gaudio’s medical journey spans over two decades in hematology and oncology. Since April 2024, he serves as an Assistant Professor at University LUM Giuseppe Degennaro and practices medicine at “F. Miulli” Regional Hospital. Prior to this, he was a senior hematologist at Policlinico Consorziale, AOU Bari for nearly 19 years, providing expert care and engaging in impactful research. He also worked at Ospedali Riuniti in Foggia, honing his clinical foundations. His experience includes leadership in clinical trials, management of complex hematologic malignancies, and therapeutic protocol development. He is a sought-after speaker, educator, and research collaborator with exposure to international institutions including Sloan-Kettering (USA), Imperial College (UK), and VHIO (Spain). His long-standing service and global outreach reflect deep dedication to patient care, academic excellence, and translational medicine.

🔬 Research Focus:

Prof. Gaudio’s research focuses on lymphomas, leukemias, and hematopoietic stem cell transplantation, combining clinical acumen with molecular innovation. As Principal Investigator in numerous global trials, he has helped shape advanced therapeutic strategies and enhance survival in hematological malignancies. His work delves into mobilization of CD34+ stem cells, radiotherapy-induced toxicity, and biological markers of malignancy. Recent systematic reviews explore epithelial–mesenchymal transcription factors, BPDCN, and the neurological impact of cannabidiol. His interests also span survivorship in Hodgkin lymphoma patients, with emphasis on long-term toxicity and risk evaluation. His teaching integrates updated scientific evidence into medical curricula, training the next generation of hematologists. International collaborations and cross-border research highlight his commitment to innovation and best practices in oncology. Prof. Gaudio’s work not only advances hematology but also bridges clinical gaps through interdisciplinary solutions.

📚 Publications Top Notes:

📄 Exploring the Role of Epithelial–Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review 🔬🧬

📄 Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced Toxicity 🎗️📊

📄 Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34+ cells in patients with relapsed-refractory diffuse large B-cell lymphomas 🩸💉

📄 The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review 🌿🧠

📄 Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview 🔎🧫

📝 Conclusion:

Prof. Francesco Gaudio is a highly qualified and deserving candidate for the Best Researcher Award. His two decades of contribution to hematology and oncology, combined with a prolific publication record, international collaboration, and dedication to clinical innovation, clearly demonstrate excellence in medical research. While opportunities exist for expanded authorship leadership and grant visibility, his current achievements are deeply impactful and relevant to modern hematologic science. His work bridges bench-to-bedside approaches and continues to benefit both the scientific community and patient outcomes.